Article
Discovery of novel serum metabolic biomarkers in patients with polycystic ovarian syndrome and premature ovarian failure
1 Jan 2021
Abstract excerpt
Several widely recognized metabolites play a role in regulating the pathophysiological processes of various disorders. Nonetheless, the lack of effective biomarkers for the early diagnosis of polycystic ovarian syndrome (PCOS) and premature ovarian failure (POF) has led to the discovery of serum-based metabolic biomarkers for these disorders. We aimed to identify various differentially expressed metabolites...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
